FOXO Technologies Regains NYSE Compliance with Equity Boost

An update from FOXO Technologies ( (FOXO) ) is now available.

FOXO Technologies Inc. announced that it has regained compliance with NYSE American’s continued listing requirements by increasing its stockholders’ equity to over $4 million through recent transactions. The company achieved this by exchanging debt for equity involving various stakeholders and aims to eliminate the risk of delisting, enhancing its stability and commitment to shareholder growth.

More about FOXO Technologies

FOXO Technologies Inc. operates in the biotechnology industry and focuses on improving human health and life span through innovative technology and product solutions. It owns and operates three subsidiaries, including Foxo Labs, Inc., a biotechnology company, Myrtle Recovery Centers, Inc., a behavioral health facility, and Rennova Community Health, Inc., which operates a hospital in East Tennessee.

YTD Price Performance: 41.07%

Average Trading Volume: 48,620,136

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $7.86M

For an in-depth examination of FOXO stock, go to TipRanks’ Stock Analysis page.